Stay updated on Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating access is blocked, instead of displaying the study record content. This blocks viewing the study details and navigation, and does not represent a substantive update to the page's information.SummaryDifference18%

- Check36 days agoChange DetectedThe page footer now displays Revision: v3.6.6, reflecting a platform update. There are no changes to trial details, eligibility criteria, or results indicated by this update.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page footer now shows Revision: v3.6.5 instead of v3.6.4. This indicates a software update to the site, with no changes to the study content or data.SummaryDifference0.0%

- Check72 days agoChange DetectedVersion revision updated from v3.6.3 to v3.6.4, indicating a site maintenance update. This reflects an under-the-hood software update across the pages rather than changes to the study content.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing Revision: v3.6.2, indicating a new revision of the page was published.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer release of the page. This update typically includes maintenance or minor fixes rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.